Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-10 00:05 | 2022-11-07 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Officer; Chief Business Officer | Pharmaceutical Preparations | BUY | $5.16 | 30,000 | $154,800 | 89,512 | +50.4% |
| 2022-03-05 00:13 | 2022-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Officer; Chief Business Officer | Pharmaceutical Preparations | SALE | $12.01 | 4,849 | $58,236 | 59,512 | -7.5% |
| 2021-11-13 00:18 | 2021-11-09 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Officer; Chief Business Officer | Pharmaceutical Preparations | OPT+S | $30.25 | 150,000 | $4,537,275 | 55,861 | -72.9% |
| 2021-11-03 23:20 | 2021-11-01 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Officer; Chief Business Officer | Pharmaceutical Preparations | OPT+S | $31.64 | 45,000 | $1,423,800 | 176,861 | -20.3% |
| 2021-09-22 23:31 | 2021-09-20 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Officer; Chief Business Officer | Pharmaceutical Preparations | OPT+S | $23.44 | 116,000 | $2,718,727 | 176,861 | -39.6% |
| 2021-09-17 00:01 | 2021-09-14 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Officer; Chief Business Officer | Pharmaceutical Preparations | OPT+S | $21.78 | 44,000 | $958,219 | 176,861 | -19.9% |
| 2021-09-15 01:16 | 2021-09-10 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Officer; Chief Business Officer | Pharmaceutical Preparations | OPT+S | $20.89 | 115,000 | $2,402,212 | 176,861 | -39.4% |
| 2021-09-08 23:04 | 2021-09-07 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Officer; Chief Business Officer | Pharmaceutical Preparations | SALE | $18.10 | 7,500 | $135,750 | 176,861 | -4.1% |
| 2021-08-27 23:09 | 2021-08-26 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Officer; Chief Business Officer | Pharmaceutical Preparations | SALE | $17.81 | 22,500 | $400,725 | 184,361 | -10.9% |
| 2021-08-10 23:09 | 2021-08-09 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Officer; Chief Business Officer | Pharmaceutical Preparations | SALE | $16.01 | 5,000 | $80,050 | 206,861 | -2.4% |
| 2021-07-29 23:09 | 2021-07-28 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Officer; Chief Business Officer | Pharmaceutical Preparations | SALE | $13.86 | 5,000 | $69,300 | 211,861 | -2.3% |
| 2021-06-23 23:06 | 2021-06-22 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Officer; Chief Business Officer | Pharmaceutical Preparations | SALE | $13.76 | 5,000 | $68,800 | 216,861 | -2.3% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.